Serum Institute Will Make Sputnik V Vaccine For India; 5 Cr Pfizer Vaccines Coming To India

The Serum Institute of India has finally been granted the permission to manufacture the Sputnik V coronavirus jab 

Additionally, more than 50 million Pfizer vaccines are on their way to India.

Read on to find out all the details!

Serum Institute Given Permission To Manufacture Sputnik V Vaccine

The Serum Institute has been given the go ahead to manufacture the Sputnik V coronavirus jab that can be used for examination, test and analysis of the COVID-19 virus. The Serum Institute had applied to the Drug Controller General of India asking permission for the same just days before.

As per an official source, “The DCGI has granted permission to the Serum Institute to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis at its licensed Hadapsar facility with certain conditions.”

For this, the SII has teamed up with the Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia

Apparently, four conditions have been set by the DGCI, in order to proceed with the manufacturing. The SII will be required to submit a copy of the agreement between the SII and the Gamaleya Research Institute of Epidemiology and Microbiology about the transfer of cell bank and virus stock. The copy of agreement of technology transfer with Gamaleya should also be submitted. 

A copy of the RCGM permission should also be submitted which clarifies the permission to import cell bank and virus stock along with the permission to initiate research and development of viral vector vaccine Sputnik V

The Russian vaccine should be administered in two doses with a gap of 21 days. As per Gamaleya, two doses of Sputnik V have an efficacy rate of 91% whereas, a single dose has 79.4%. Gamaleya has also stated that the vaccine has been approved in 65 countries till now. 

More Than 50 Million Pfizer Vaccines Coming To India

In addition to this, there are reports that about 50-60 million doses of Pfizer’s coronavirus vaccine are on their way to India. This news comes to us while there are talks about a “partial indemnity” on the impact of the vaccine.

The sources have said that the Pfizer vaccine will not be given a complete waiver by India. They have also confirmed that “reactions to the vaccine are indemnified” but the “reaction amounting to death or serious ailment like paralysis can’t be given waiver and will carry liability”.

The Pfizer vaccine by Pfizer-BioNTech is an  mRNA vaccine that instructs the cells to generate the spike protein found on the surface of the novel coronavirus, thereby generating an immune response.